Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

RSS icon
Video of Peter Monteleone, MD, discusses role of cardiology in pulmonary embolism response teams (PERT). CT image of the heart showing bilateral pulmonary embolism blood clots in the pulmonary arteries leading into the lungs.

Interventional cardiology sees growing role in pulmonary embolism interventions

Peter Monteleone, MD, national director of cardiovascular research at Ascension Health, explains the growing role of interventional cardiology in pulmonary embolism treatment and PERT teams.

money business cash flow dollar

It’s official: Johnson & Johnson completes $13B Shockwave Medical acquisition

The deal, first announced in April, has been finalized. Shockwave will now operate as a business unit within Johnson & Johnson MedTech, and its common stock is no longer trading on NASDAQ.

Women remain underrepresented in revascularization trials—can cardiology leaders reverse that trend?

“If together we do not just hope for, but demand, adequate representation as a necessary criterion for high-quality studies worthy of adoption into practice, we will have a real shot at achieving true equity in our trials," cardiologists said in a new commentary.

money business cash flow dollar

Medical device company raises $87M to study new-look scaffolds for BTK PAD

R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO. 

PCI interventional cardiology

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients. 

Abbott's Espirit BTK Everolimus Eluting Resorbable Scaffold gained U.S. FDA approval in April 2024. It is based on the former Abbott Absorb coronary stent, but indicated for use in peripheral artery lesions below the knee (BTK).

FDA approves Abbott’s resorbable stent for BTK arteries

The bioresorbable stent, examined at length for the LIFE-BTK clinical trial, stays in place for up to three years before completely dissolving. 

FDA clears ICE Aspiration System

FDA clears new catheter for peripheral blood clots

The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space. 

TAVR JenaValve Trilogy Heart Valve System pure AR

Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation

The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.

Displaying 25 - 32 of 495

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

 

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup